Logo image
Back
Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis
Journal article   Open access   Peer reviewed

Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis

Usman Mustafa, Parinita Dherange, Rohit Reddy, Joseph DeVillier, Jessica Chong, Alarozia Ihsan, Ryan Jones, Narendra Duddyala, Pratap Reddy and Paari Dominic
Journal of the American Heart Association, Vol.7(22), pp.e010156-e010156
11/20/2018
DOI: 10.1161/JAHA.118.010156
PMCID: PMC6404454
PMID: 30554547
url
https://doi.org/10.1161/jaha.118.010156View
Published (Version of record) Open Access

Abstract

Background-Implantable cardioverter-defibrillator (ICD) improves survival when used for primary or secondary prevention of sudden cardiac death. Whether the benefits of ICD in patients with atrial fibrillation (AF) are similar to those with normal sinus rhythm (NSR) is not well established. The aim of this study is to investigate whether ICD patients with AF are at higher risk of mortality and appropriate shock therapy compared with patients with NSR. Methods and Results-Literature was searched and 25 observational studies with 63 283 patients were included in this metaanalysis. We compared the outcomes of (1) all-cause mortality and appropriate shock therapy among AF and NSR patients who received ICD for either primary or secondary prevention and (2) all-cause mortality among AF patients with ICD versus guideline directed medical therapy. All-cause mortality (odds ratio, 2.11; 95% confidence interval, 1.73-2.56; P< 0.001) and incidence of appropriate shock therapy (odds ratio, 1.77; 95% confidence interval, 1.47-2.13; P < 0.001) were significantly higher in ICD patients with AF as compared to NSR. There was no statistically significant mortality benefit from ICD compared with medical therapy in AF patients (odds ratio, 0.69; 95% confidence interval, 0.42-1.11; P= 0.12) based on a separate meta-analysis of 3 studies with 387 patients. Conclusions-Overall mortality and appropriate shock therapy are higher in ICD patients with AF as compared with NSR. The impact of ICD on all-cause mortality in AF patients when compared to goal-directed medical therapy is unclear, and randomized controlled trials are needed comparing AF patients with ICD and those who have indications for ICD, but are only on medical therapy.
 Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Life Sciences & Biomedicine Science & Technology

Details

Metrics

16 Record Views
23 Times Cited - Web of Science
Logo image